Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 21 points (0.1%) at 16,093 as of Tuesday, Nov. 26, 2013, 11:45 AM ET. The NYSE advances/declines ratio sits at 1,560 issues advancing vs. 1,331 declining with 131 unchanged. The Health Services industry currently sits up 0.5% versus the S&P 500, which is up 0.1%. On the negative front, top decliners within the industry include ResMed ( RMD), down 2.2%, and Waters Corporation ( WAT), down 1.4%. TheStreet would like to highlight 5 stocks pushing the industry lower today: 5. DaVita HealthCare Partners ( DVA) is one of the companies pushing the Health Services industry lower today. As of noon trading, DaVita HealthCare Partners is down $0.97 (-1.6%) to $60.58 on average volume. Thus far, 1.1 million shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $60.50-$61.69 after having opened the day at $61.46 as compared to the previous trading day's close of $61.55. DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $12.0 billion and is part of the health care sector. The company has a P/E ratio of 21.3, above the S&P 500 P/E ratio of 17.7. Shares are up 2.3% year to date as of the close of trading on Monday. Currently there are 7 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 5 rate it a hold. TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full DaVita HealthCare Partners Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.